Pfizer, Inc. vs Zimmer Biomet Holdings, Inc. — Stock Comparison
Q·Score Breakdown
6.5
Neutral
Overall
6.9
Neutral
Quality
Health
Growth
Valuation
Sentiment
PFE
Strong profitability with 12% net profit margins.
⚠ analyst sentiment is cautious.
ZBH
Earnings growing 34% year-over-year on 9% revenue growth.
⚠ cautious analyst consensus — few Buy ratings.
Analyst Consensus
HOLD
Target $29.00 (+10.2%)
27 analysts
HOLD
Target $98.52 (+18.8%)
21 analysts
Fundamentals
PFE
ZBH
19.4×
Trailing P/E
21.5×
9.4×
Forward P/E
9.2×
12.4%
Profit Margin
9.1%
75.8%
Gross Margin
70.2%
8.9%
ROE
6.1%
-1.2%
Revenue Growth
9.3%
—
Earnings Growth
34.1%
0.39
Beta
0.61
—
Price / Book
—
$149.8B
Market Cap
$16.0B
$22 – $29
52-Week Range
$80 – $108
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →